Nipro’s Nexium AG Grabs 53% Market Share in Just 4 Months

May 22, 2023
Nipro’s authorized generic (AG) version of Nexium (esomeprazole) held a share of 53% in the entire market of esomeprazole including AstraZeneca’s original product as of the end of March 2023, less than four months after its rollout in Japan, a...read more